This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakai, H.
Right arrow Articles by Kay, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakai, H.
Right arrow Articles by Kay, M. A.

 Previous Article  |  Next Article 

Journal of Virology, August 2001, p. 6969-6976, Vol. 75, No. 15
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.15.6969-6976.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In Vivo

Hiroyuki Nakai, Stephen R. Yant, Theresa A. Storm, Sally Fuess, Leonard Meuse, and Mark A. Kay*

Departments of Pediatrics and Genetics, Stanford University School of Medicine, Stanford, California 94305

Received 15 February 2001/Accepted 29 April 2001

Recombinant adeno-associated virus (rAAV) vectors stably transduce hepatocytes in experimental animals. Although the vector genomes are found both as extrachromosomes and as chromosomally integrated forms in hepatocytes, the relative proportion of each has not yet been clearly established. Using an in vivo assay based on the induction of hepatocellular regeneration via a surgical two-thirds partial hepatectomy, we have determined the proportion of integrated and extrachromosomal rAAV genomes in mouse livers and their relative contribution to stable gene expression in vivo. Plasma human coagulation factor IX (hF.IX) levels in mice originating from a chromosomally integrated hF.IX-expressing transposon vector remained unchanged with hepatectomy. This was in sharp contrast to what was observed when a surgical partial hepatectomy was performed in mice 6 weeks to 12 months after portal vein injection of a series of hF.IX-expressing rAAV vectors. At doses of 2.4 × 1011 to 3.0 × 1011 vector genomes per mouse (n = 12), hF.IX levels and the average number of stably transduced vector genomes per cell decreased by 92 and 86%, respectively, after hepatectomy. In a separate study, one of three mice injected with a higher dose of rAAV had a higher proportion (67%) of integrated genomes, the significance of which is not known. Nevertheless, in general, these results indicate that, in most cases, no more than ~10% of stably transduced genomes integrated into host chromosomes in vivo. Additionally, the results demonstrate that extrachromosomal, not integrated, genomes are the major form of rAAV in the liver and are the primary source of rAAV-mediated gene expression. This small fraction of integrated genomes greatly decreases the potential risk of vector-related insertional mutagenesis associated with all integrating vectors but also raises uncertainties as to whether rAAV-mediated hepatic gene expression can persist lifelong after a single vector administration.


* Corresponding author. Mailing address: Departments of Pediatrics and Genetics, 300 Pasteur Dr., Room G305A, Stanford University, Stanford, CA 94305. Phone: (650) 498-6531. Fax: (650) 498-6540. E-mail: markay{at}stanford.edu.


Journal of Virology, August 2001, p. 6969-6976, Vol. 75, No. 15
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.15.6969-6976.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Anisimov, A., Alitalo, A., Korpisalo, P., Soronen, J., Kaijalainen, S., Leppanen, V.-M., Jeltsch, M., Yla-Herttuala, S., Alitalo, K. (2009). Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle. Circ. Res. 104: 1302-1312 [Abstract] [Full Text]  
  • Barde, I., Laurenti, E., Verp, S., Groner, A. C., Towne, C., Padrun, V., Aebischer, P., Trumpp, A., Trono, D. (2009). Regulation of Episomal Gene Expression by KRAB/KAP1-Mediated Histone Modifications. J. Virol. 83: 5574-5580 [Abstract] [Full Text]  
  • Niemeyer, G. P., Herzog, R. W., Mount, J., Arruda, V. R., Tillson, D. M., Hathcock, J., van Ginkel, F. W., High, K. A., Lothrop, C. D. Jr (2009). Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. Blood 113: 797-806 [Abstract] [Full Text]  
  • Inagaki, K., Piao, C., Kotchey, N. M., Wu, X., Nakai, H. (2008). Frequency and Spectrum of Genomic Integration of Recombinant Adeno-Associated Virus Serotype 8 Vector in Neonatal Mouse Liver. J. Virol. 82: 9513-9524 [Abstract] [Full Text]  
  • Penaud-Budloo, M., Le Guiner, C., Nowrouzi, A., Toromanoff, A., Cherel, Y., Chenuaud, P., Schmidt, M., von Kalle, C., Rolling, F., Moullier, P., Snyder, R. O. (2008). Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle. J. Virol. 82: 7875-7885 [Abstract] [Full Text]  
  • Inagaki, K., Ma, C., Storm, T. A., Kay, M. A., Nakai, H. (2007). The Role of DNA-PKcs and Artemis in Opening Viral DNA Hairpin Termini in Various Tissues in Mice. J. Virol. 81: 11304-11321 [Abstract] [Full Text]  
  • Inagaki, K., Lewis, S. M., Wu, X., Ma, C., Munroe, D. J., Fuess, S., Storm, T. A., Kay, M. A., Nakai, H. (2007). DNA Palindromes with a Modest Arm Length of {gtrsim}20 Base Pairs Are a Significant Target for Recombinant Adeno-Associated Virus Vector Integration in the Liver, Muscles, and Heart in Mice. J. Virol. 81: 11290-11303 [Abstract] [Full Text]  
  • Wang, J., Xie, J., Lu, H., Chen, L., Hauck, B., Samulski, R. J., Xiao, W. (2007). Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction. Proc. Natl. Acad. Sci. USA 104: 13104-13109 [Abstract] [Full Text]  
  • Veron, P., Allo, V., Riviere, C., Bernard, J., Douar, A.-M., Masurier, C. (2007). Major Subsets of Human Dendritic Cells Are Efficiently Transduced by Self-Complementary Adeno-Associated Virus Vectors 1 and 2. J. Virol. 81: 5385-5394 [Abstract] [Full Text]  
  • Nathwani, A. C., Gray, J. T., Ng, C. Y. C., Zhou, J., Spence, Y., Waddington, S. N., Tuddenham, E. G. D., Kemball-Cook, G., McIntosh, J., Boon-Spijker, M., Mertens, K., Davidoff, A. M. (2006). Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 107: 2653-2661 [Abstract] [Full Text]  
  • Grimm, D., Pandey, K., Nakai, H., Storm, T. A., Kay, M. A. (2006). Liver Transduction with Recombinant Adeno-Associated Virus Is Primarily Restricted by Capsid Serotype Not Vector Genotype. J. Virol. 80: 426-439 [Abstract] [Full Text]  
  • Miller, D. G., Trobridge, G. D., Petek, L. M., Jacobs, M. A., Kaul, R., Russell, D. W. (2005). Large-Scale Analysis of Adeno-Associated Virus Vector Integration Sites in Normal Human Cells. J. Virol. 79: 11434-11442 [Abstract] [Full Text]  
  • Wang, L., Calcedo, R., Nichols, T. C., Bellinger, D. A., Dillow, A., Verma, I. M., Wilson, J. M. (2005). Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood 105: 3079-3086 [Abstract] [Full Text]  
  • Nakai, H., Wu, X., Fuess, S., Storm, T. A., Munroe, D., Montini, E., Burgess, S. M., Grompe, M., Kay, M. A. (2005). Large-Scale Molecular Characterization of Adeno-Associated Virus Vector Integration in Mouse Liver. J. Virol. 79: 3606-3614 [Abstract] [Full Text]  
  • Yant, S. R., Wu, X., Huang, Y., Garrison, B., Burgess, S. M., Kay, M. A. (2005). High-Resolution Genome-Wide Mapping of Transposon Integration in Mammals. Mol. Cell. Biol. 25: 2085-2094 [Abstract] [Full Text]  
  • Nakai, H., Fuess, S., Storm, T. A., Muramatsu, S.-i., Nara, Y., Kay, M. A. (2005). Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice. J. Virol. 79: 214-224 [Abstract] [Full Text]  
  • Mendell, J. R., Miller, A. (2004). Gene transfer for neurologic disease: Agencies, policies, and process. Neurology 63: 2225-2232 [Abstract] [Full Text]  
  • Thomas, C. E., Storm, T. A., Huang, Z., Kay, M. A. (2004). Rapid Uncoating of Vector Genomes Is the Key to Efficient Liver Transduction with Pseudotyped Adeno-Associated Virus Vectors. J. Virol. 78: 3110-3122 [Abstract] [Full Text]  
  • Wells, P. G., Mackenzie, P. I., Roy Chowdhury, J., Guillemette, C., Gregory, P. A., Ishii, Y., Hansen, A. J., Kessler, F. K., Kim, P. M., Roy Chowdhury, N., Ritter, J. K. (2004). GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE. Drug Metab. Dispos. 32: 281-290 [Abstract] [Full Text]  
  • Song, S., Lu, Y., Choi, Y.-K., Han, Y., Tang, Q., Zhao, G., Berns, K. I., Flotte, T. R. (2004). DNA-dependent PK inhibits adeno-associated virus DNA integration. Proc. Natl. Acad. Sci. USA 101: 2112-2116 [Abstract] [Full Text]  
  • Chu, D., Sullivan, C. C., Weitzman, M. D., Du, L., Wolf, P. L., Jamieson, S. W., Thistlethwaite, P. A. (2003). Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors. J. Thorac. Cardiovasc. Surg. 126: 671-679 [Abstract] [Full Text]  
  • Davidoff, A. M., Ng, C. Y. C., Zhou, J., Spence, Y., Nathwani, A. C. (2003). Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood 102: 480-488 [Abstract] [Full Text]  
  • Ehrhardt, A., Xu, H., Kay, M. A. (2003). Episomal Persistence of Recombinant Adenoviral Vector Genomes during the Cell Cycle In Vivo. J. Virol. 77: 7689-7695 [Abstract] [Full Text]  
  • Gao, G., Alvira, M. R., Somanathan, S., Lu, Y., Vandenberghe, L. H., Rux, J. J., Calcedo, R., Sanmiguel, J., Abbas, Z., Wilson, J. M. (2003). Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. USA 100: 6081-6086 [Abstract] [Full Text]  
  • Duan, D., Yue, Y., Engelhardt, J. F. (2003). Consequences of DNA-Dependent Protein Kinase Catalytic Subunit Deficiency on Recombinant Adeno-Associated Virus Genome Circularization and Heterodimerization in Muscle Tissue. J. Virol. 77: 4751-4759 [Abstract] [Full Text]  
  • Schnepp, B. C., Clark, K. R., Klemanski, D. L., Pacak, C. A., Johnson, P. R. (2003). Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle. J. Virol. 77: 3495-3504 [Abstract] [Full Text]  
  • Nakai, H., Thomas, C. E., Storm, T. A., Fuess, S., Powell, S., Wright, J. F., Kay, M. A. (2002). A Limited Number of Transducible Hepatocytes Restricts a Wide-Range Linear Vector Dose Response in Recombinant Adeno-Associated Virus-Mediated Liver Transduction. J. Virol. 76: 11343-11349 [Abstract] [Full Text]  
  • Favre, D., Blouin, V., Provost, N., Spisek, R., Porrot, F., Bohl, D., Marme, F., Cherel, Y., Salvetti, A., Hurtrel, B., Heard, J.-M., Riviere, Y., Moullier, P. (2002). Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus. J. Virol. 76: 11605-11611 [Abstract] [Full Text]  
  • Nathwani, A. C., Davidoff, A. M., Hanawa, H., Hu, Y., Hoffer, F. A., Nikanorov, A., Slaughter, C., Ng, C. Y. C., Zhou, J., Lozier, J. N., Mandrell, T. D., Vanin, E. F., Nienhuis, A. W. (2002). Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood 100: 1662-1669 [Abstract] [Full Text]  
  • Wang, Y., Camp, S. M., Niwano, M., Shen, X., Bakowska, J. C., Breakefield, X. O., Allen, P. D. (2002). Herpes Simplex Virus Type 1/Adeno-Associated Virus rep+ Hybrid Amplicon Vector Improves the Stability of Transgene Expression in Human Cells by Site-Specific Integration. J. Virol. 76: 7150-7162 [Abstract] [Full Text]